Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Actelion Pharmaceuticals

Biotech & Life Sciences · Baden, Switzerland · Founded 1997 · IPO 2013 Decacorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$30B
Market cap · 2026
Revenue
$2.45B
Latest reported FY

Investors

4 investors on Actelion Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage
Reference Capital
Atlas Venture
Sofinnova Partners
HealthCap

Global footprint

Where Actelion Pharmaceuticals has talent and traffic

AI talent share
0.2% of workforce is AI talent
(1 of 465 staff)
Core AI00%
Other AI10.22%
Non-AI workforce46499.78%
Web traffic by country
770 monthly visits
across markets
🇬🇧 United Kingdom103.9%
Top 1 markets shown

Patent intelligence

$361M patent portfolio · 132 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$361M
1.2% of market cap · comparable to top peer Reata Pharmaceuticals ($354M)
132 active patent families
Where Actelion Pharmaceuticals innovates Medicinal chemistryPharmaceutical SubstancesPerylene derivativesPharmacologyStereochemistry
Below peer median on Legal, Market, Technology

Quality vs same-sector peers

Actelion Pharmaceuticals on the five Patsnap quality dimensions

Actelion Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Actelion Pharmaceuticals concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Actelion Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Actelion Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo